Abstract

Background :Venous thromboembolism (VTE) is a universal health problem` which causes mortality. Prophylaxis of venous thromboembolism is useful in decreasing mortality and morbidity rates. There is a worldwide deficiency in awareness about venous thromboembolism.

Aims :To investigate the knowledge, attitude, and practice of venous thromboembolism prophylaxis between medical staff in Saudi medical community before and after a training workshop.

Materials and Methods :This study includes three medical professions from 20 rural hospitals in Saudi Arabia. A survey was used to record their answers. Data analyzed using suitable statistical methods.

Results :Training has a significant (p < 0.001) positive impact on the awareness of the availability of VTE guidelines (39.9% and 90.9%) before and after training, respectively. Also, the availability of risk assessment form has been increased (p < 0.001) after training (37.5% and 89.1%) before and after training, respectively. Participants’ prescription of VTE prophylaxis for patients upon admission was significantly (p-value < 0.001) increased (23.2% and 67.6%) before and after training, respectively. Before training, most of the hospitals had no mechanical prophylaxis devices (84.3%). However, after training this percent decreased (38.9%) significantly (p < 0.001). The most prevalent barrier to implement thromboprophylaxis guidelines fully was that each physician had his own approach to provide thromboprophylaxis (50.2%). That was decreased significantly (p < 0.001) after training (35.6%).

Conclusion :Training and education are very important to help increase the awareness and to change attitudes of health care providers toward VTE prophylaxis. Addressing the barriers toward VTE prophylaxis implementation is necessary. Health care providers are willing to help in planning and implementation and this is an excellent strategy for implementation of VTE prophylaxis.

Keywords: VTE; VTE Prophylaxis; VTE Guidelines; Training; Attitude

References

1. “The Surgeon General’s Call to Action to Prevent Deep Vein Thrombosis and Pulmonary Embolism”. Office of the Surgeon General. U.S. Department of Health and Human Services. Washington, DC (2011).
2. Tapson VF., et al. “Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism”. Chest3 (2007): 936-945.
3. Ruppert A., et al. “Economic burden of venous thromboembolism: a systematic review”. Journal of Medical Economics1 (2011): 65-74.
4. Cohen AT., et al. “Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality”. Thrombosis and Haemostasis 98 (2007): 756-764.
5. ISTH Steering Committee for World Thrombosis Day. Thrombosis: “a major contributor to the global disease burden”. Journal of Thrombosis and Haemostasis10 (2014): 1580-1590.
6. Heit JA. “Epidemiology of venous thromboembolism”. Nature Reviews Cardiology 8 (2015): 464-474.
7. Saxena A., et al. “Safety and efficacy of low-molecular-weight heparins in prophylaxis of deep vein thrombosis in postoperative/ICU patients: A comparative study”. Journal of Natural Science, Biology, and Medicine 1 (2013): 197-200.
8. “Data and Statistics on Venous Thromboembolism”. Centers for Disease Control and Prevention (2015).
9. Beckman MG., et al. “Venous thromboembolism: a public health concern”. American Journal of Preventive Medicine 4 (2010): S495-S501.
10. Essam AE., et al. “Venous thromboembolism-related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia”. Annals of Thoracic Medicine4 (2011): 193-198.
11. Linda MD., et al. “Economic Evaluation of Enoxaparin as Post-discharge Prophylaxis for Deep Vein Thrombosis (DVT) in Elective Hip Surgery”. Value in Health 3 (2008): 398-406.
12. Catterick D., et al. “Impact of the national venous thromboembolism risk assessment tool in secondary care in England: retrospective population-based database study”. Blood Coagulation and Fibrinolysis 25 (2014): 571-576.
13. Ekwere TA., et al. “Venous thromboembolism: awareness and practice of thromboprophylaxis among physicians in a tertiary-care hospital”. International Journal of Medicine and Biomedical Research 1 (2015): 14-20.
14. Cohen AT., et al. “ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial”. British Medical Journal 332 (2006): 325-329.
15. Cayley jr WE. “Preventing deep venous thrombosis in hospital in-patients”. British Medical Journal 335 (2007): 147-151.
16. Gould MK., et al. “Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy”. Chest 141 (2012): e227S-e277S.
17. Al-Hameed FM. “Venous thromboembolism prophylaxis: Solutions are in our hands”. Annals of Thoracic Medicine 3 (2011): 105-106.
18. Serigne AB., et al. “A cross sectional evaluation of venous thromboembolism risk and use of venous thromboembolism prophylaxis in hospitalized patients in Senegal”. Archives of Cardiovascular Diseases 104 (2011): 493-501.
19. Cohen AT., et al. “ENDORSE Investigators. Venous thromboembolism, risk and prophylaxis in the acute hospital care setting (ENDORSE study): A multinational cross-sectional study”. Lancet 371 (2008):387-394.
20. Kahn SR., et al. “CURVE study investigators. Multicenter evaluation of the use of venous thromboembolism prophylaxis in acutely ill medical patients in Canada”. Thrombosis Research 119 (2007): 145-155.
21. Kharaba A., et al. “Venous thromboembolism risks and prophylaxis in King Fahad Hospital, Madinah, Saudi Arabia”. Journal of Epidemiology and Global Health4 (2017): 295-298.
22. Zobeiri M., et al. “Prophylaxis for deep venous thrombosis: Knowledge and practice of surgeons”. Pakistan Journal of Medical Sciences 1 (2011): 16-20.
23. Bhatti AM., et al. “Knowledge, Attitude and Practices of Healthcare Providers towards Deep Vein Thrombosis Prophylaxis in Five Teaching Hospitals of Rawalpindi”. Journal of Ayub Medical College Abbottabad 2 (2012).
24. Tang X., et al. “A Survey of the Knowledge of Venous Thromboembolism Prophylaxis among the Medical Staff of Intensive Care Units in North China”. PLOS ONE (2015).
25. Schaden E., et al. “Coagulation Day 2010: an Austrian survey on the routine of thromboprophylaxis in intensive care”. Intensive Care Medicine6 (2012): 984-990.
26. Ebrahimpur M., et al. “Knowledge, Attitudes and Practices of Internal Medicine Residents Towards Deep Vein Thrombosis Prophylaxis in a University Hospital in Tehran”. Shiraz E Medical Journal 12 (2016): e39038.
27. Cook D., et al. “Barriers and facilitators of thromboprophylaxis for medical and surgical Intensive care unit patients: a multicenter survey”. The Journal of Critical Care 29 (2014): 471-479.
28. Cabana MD., et al. “Why don’t physicians follow Clinical practice guidelines? A framework for improvement”. The Journal of the American Medical Association 282 (1999): 1458-1456.
29. Scaglione L., et al. “Implementing guidelines for venous thromboembolism prophylaxis in a large Italian teaching hospital: lights and shadows”. Haematologica5 (2005): 678-684.
30. Tooher R., et al. “A systematic review of strategies to improve prophylaxis for venous thromboembolism in hospitals”. Annals of Surgery 241 (2005): 397-415.
31. Cohn SL., et al. “Improved use of thromboprophylaxis for deep vein thrombosis following an educational intervention”. Journal of Hospital Medicine 6 (2006): 331-338.

Citation

Citation: Emad R Issak., et al. “Do Training Programs Change the Attitude of Health Care Providers toward Venous Thromboembolism Prophylaxis?". Acta Scientific Medical Sciences 4.9 (2020): 137-144.

Copyright

Copyright: © 2020 Emad R Issak., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.